Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

Air pollution is responsible for 102,456 deaths annually in Bangladesh, as per a new study by the Centre for Research on ...

Dr. Suresh Vedantham asks Drs. Pavan Kavali and Kristen Sanfilippo about possible benefits of a DVT response team model, ...

Learn how personalized exercise routines can transform your COPD journey, enhance resilience, and improve your quality of ...

Neighborhood socioeconomic deprivation is independently linked to worse follow-up adherence for incidentally found pulmonary nodules.

Leerink Partners analyst Faisal Khurshid has reiterated their bullish stance on PLRX stock, giving a Buy rating on January 15.Stay Ahead of ...

Verona Pharma stock hit a record high Thursday on continued enthusiasm for its newly launched COPD treatment, Ohtuvayre.

Aileron Therapeutics pulled a hard pivot in 2023, merging with Lung Therapeutics to gain a new pipeline and investor base. | ...

Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...

Taken together with Keros’ recent pivot away from obesity, the termination of its pulmonary arterial hypertension study could ...

Sex-related differences in pulmonary complications were found among men vs women with SSc, specifically in the prevalence of ILD and SAD.